Survival analysis of a 16-year cohort of follicular lymphoma patients receiving systemic treatment in Brazil
In light of the substantial advancements achieved by the SUS, there is a need for CONITEC to expedite decision-making processes in order to enhance patients access to new oncology drugs. This should be done while upholding health technology assessment standards. Timely integration and sufficient funding for oncology services have the potential to save lives, especially when compared to the treatments available within SUS at that time.
Authors
- Dirce Ribeiro de Oliveira (ORCID: https://orcid.org/0000-0003-4592-0508)
- Juliana Álvares-Teodoro (ORCID: https://orcid.org/0000-0002-0210-0721)
- Marina Morgado Garcia (ORCID: https://orcid.org/0000-0002-7418-2586)
- Wallace Mateus Prata (ORCID: https://orcid.org/0000-0002-8426-6994)
- Francisco de Assis Acúrcio (ORCID: https://orcid.org/0000-0002-5880-5261)
- Pâmela Santos Azevedo (ORCID: https://orcid.org/0000-0002-1947-6290)
- Augusto Afonso Guerra (ORCID: https://orcid.org/0000-0001-5256-0577)
- Mariângela Leal Cherchiglia (ORCID: https://orcid.org/0000-0001-5622-567X)
- Isabela Freitas (ORCID: https://orcid.org/0009-0009-0674-8187)
- Adriano de Paula Sabino
- Isabella Zuppo Laper
Institutions
- Universidade Federal de Minas Gerais (BR)
- Ezequiel Dias Foundation (BR)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-01-10
- DOI
- https://doi.org/10.3389/fphar.2024.1414244
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47